Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael H. Mulroy currently holds 75,000 shares of Lineage Cell Therapeutics, Inc. (LCTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael H. Mulroy has been a net seller of LCTX stock. They have purchased $109.7K and sold $5.1M worth of shares.
Michael H. Mulroy's most recent insider trade was on Jul 1, 2024, when they sold 75,000 shares at $0.00 per share.
Michael H. Mulroy serves as Executive at Lineage Cell Therapeutics, Inc. (LCTX). They have executed 57 insider transactions totaling $5.2M over their tenure at the company.
Michael H. Mulroy holds the position of Executive at Lineage Cell Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Michael H. Mulroy has shown a selling trading pattern, with $109.7K in total purchases and $5.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael H. Mulroy was on Feb 24, 2014, when they sold $997.4K worth of QCOR shares. This transaction involved 12,552 shares at $79.46 per share.
Michael H. Mulroy currently owns 75,000 shares of Lineage Cell Therapeutics, Inc. (LCTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael H. Mulroy's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael H. Mulroy has 57 Form 4 filings on record as an insider at Lineage Cell Therapeutics, Inc..
Set alerts for Michael H. Mulroy and 40,000+ other insiders.